Safety and Efficacy Study of Axid Use in Infants Suffering From Gastroesophageal Reflux Disease (GERD)
Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the efficacy, acceptability, and safety of Axid
Oral Solution versus placebo in the treatment of gastroesophageal reflux disease (GERD) in
infants age 30 days up to 1 year.